Advertisement

Diabetes Forecast

The Healthy Living Magazine

No Cancer Link Found in Incretin Meds

losw/Thinkstock

Some data have suggested that incretin-based medications—DPP-4 inhibitors, such as sitagliptin (Januvia), and GLP-1 agonists, such as exenatide (Byetta)—are associated with the development of pancreatitis and pancreatic cancer. Over the past year, the Food and Drug Administration (FDA) and European Medicines Agency (EMA) independently  evaluated the safety of these medications using all the available data, including studies in both animals and humans. The FDA and EMA said that the evidence did not support the claim that incretin-based medications cause pancreatitis or pancreatic cancer, though the agencies will continue to study the safety of these medications.
Source: The New England Journal of Medicine, Feb. 27, 2014

 
Advertisement

Get Free Health Tips

Register for free recipes, news you can use, and simple health tips – delivered right to your inbox.

Get to Know

While she’s still spinning music, DJ Spinderella (aka Deidra Roper) is no longer spinning her wheels when it comes to getting the right information to help her family members who have diabetes. Read more >